How to Get Farxiga (Dapagliflozin) in Missouri

What Is Dapagliflozin and Why Does It Matter in Missouri?

Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor approved by the FDA for three distinct indications: type 2 diabetes, heart failure with reduced or preserved ejection fraction, and chronic kidney disease. AstraZeneca markets the drug as Farxiga. Missouri has roughly 700,000 adults living with diagnosed diabetes and a heart failure hospitalization rate that exceeds the national average by 12%, according to CDC state-level data. Access to SGLT2 inhibitors in Missouri depends on prescriber availability, insurance formulary placement, and pharmacy infrastructure.

The clinical evidence is substantial. In the DAPA-HF trial (N=4,744), dapagliflozin 10 mg reduced the composite of worsening heart failure or cardiovascular death by 26% compared to placebo (HR 0.74; 95% CI, 0.65-0.85; P<0.001). That benefit appeared regardless of whether the patient had diabetes. The DAPA-CKD trial (N=4,304) demonstrated a 39% relative risk reduction in sustained decline in eGFR of at least 50%, end-stage kidney disease, or death from renal or cardiovascular causes (Heerspink et al., NEJM 2020). These outcomes are why guideline bodies now recommend SGLT2 inhibitors early in the treatment algorithm for heart failure and CKD.

Missouri Telehealth Rules for Farxiga Prescriptions

Missouri law authorizes prescribers to write new prescriptions via telehealth, including for controlled and non-controlled medications like dapagliflozin. No in-person visit is required before the initial telehealth encounter, though the prescriber must establish a valid provider-patient relationship through a real-time audio-video consultation. Missouri enacted SB 52 in 2021, which expanded permanent telehealth parity and required private insurers to reimburse telehealth visits at the same rate as in-person encounters.

For a Missouri resident, the practical path looks like this: schedule a video visit with a licensed prescriber (MD, DO, NP, or PA), provide your lab results and medical history, and the prescriber can electronically send the Farxiga prescription to any Missouri pharmacy. The prescriber must hold an active Missouri license or a multistate license recognized under the Interstate Medical Licensure Compact. Missouri joined the compact in 2016, which means out-of-state physicians licensed through the compact can legally treat Missouri patients via telehealth.

Turnaround is fast. Most telehealth platforms complete the visit within 24 to 48 hours, and e-prescribing delivers the order to your pharmacy the same day the prescriber signs it.

Who Can Prescribe Farxiga in Missouri (MD vs. NP vs. PA)

Three categories of prescribers in Missouri can write a dapagliflozin prescription. MDs and DOs have independent prescriptive authority. Physician assistants prescribe under a collaborative practice agreement with a supervising physician, which the Missouri Division of Professional Registration requires to be filed and accessible. Nurse practitioners in Missouri operate under a collaborative practice agreement for the first 2,000 hours of prescribing, after which they gain full independent authority under the 2021 legislative update.

All three prescriber types can order the labs, write the prescription, and submit a prior authorization. The choice of prescriber type does not affect the drug's availability or insurance processing. If you already see an NP or PA for diabetes management, they can prescribe Farxiga without a referral to an endocrinologist.

Required Labs Before Starting Dapagliflozin

Every prescriber should order baseline labs before initiating dapagliflozin. This is not optional. The ADA Standards of Care (2025) and the KDIGO 2024 guidelines both specify pre-treatment lab requirements.

The standard panel includes:

• eGFR (estimated glomerular filtration rate): Dapagliflozin is approved for eGFR ≥20 mL/min/1.73 m² for heart failure and CKD indications. For type 2 diabetes, AstraZeneca's label recommends eGFR ≥25 mL/min/1.73 m².
• Serum creatinine and BUN: Baseline renal function markers.
• HbA1c: Required for the diabetes indication and often requested by insurers for prior authorization.
• Urinalysis: To rule out active urinary tract infection, since SGLT2 inhibitors increase urinary glucose and raise UTI risk.
• Basic metabolic panel: Potassium, sodium, and bicarbonate levels. Dapagliflozin can cause euglycemic diabetic ketoacidosis in rare cases (estimated incidence 0.1-0.3% per the FDA label), and baseline metabolic data helps with monitoring.

Missouri has no state-specific lab requirements beyond what the prescriber's clinical judgment and the insurer's prior authorization form demand. Quest Diagnostics and Labcorp both operate draw sites across Missouri, and many telehealth platforms accept uploaded lab results from any CLIA-certified lab completed within the prior 90 days.

Insurance and Prior Authorization in Missouri

Prior authorization is the single biggest barrier to Farxiga access in Missouri. Nearly every commercial insurer in the state requires it. Here is what the process typically involves.

Commercial insurance (UnitedHealthcare, Blue Cross Blue Shield of Kansas City, Anthem, Cigna, Aetna): Most Missouri commercial plans place Farxiga on Tier 3 (preferred brand) or Tier 4 (non-preferred brand). Prior authorization requires documentation of the specific FDA-approved indication, proof of metformin trial (for T2D), recent HbA1c or eGFR values, and prescriber attestation that the patient meets labeled criteria. Approval timelines in Missouri range from 48 hours to 14 business days. The prescriber's office submits the PA electronically through CoverMyMeds or the insurer's portal.

Missouri Medicaid (MO HealthNet): This is where access narrows. Missouri Medicaid does not cover Farxiga for type 2 diabetes as a standalone indication according to the current MO HealthNet Preferred Drug List. Coverage may be available through an exception request for heart failure or CKD, but the prescriber must document that the patient meets the FDA-approved indication and that alternative formulary drugs have been tried or are contraindicated. The Endocrine Society's clinical practice guideline on SGLT2 inhibitors supports dapagliflozin use in patients with type 2 diabetes who have established cardiovascular or renal disease, which can strengthen an appeal.

Medicare Part D: Most Medicare Part D plans in Missouri cover Farxiga with prior authorization. Since the Inflation Reduction Act capped out-of-pocket Part D spending at $2,000 per year beginning in 2025, the annual cost exposure for Farxiga has dropped significantly for Medicare beneficiaries.

AstraZeneca savings programs: The manufacturer offers a copay savings card that can reduce the out-of-pocket cost to as low as $0 per month for commercially insured patients. This card does not apply to government insurance (Medicaid, Medicare, Tricare).

What Documentation Prior Authorization Requires

The PA form for Farxiga in Missouri typically asks for five elements:

1. Diagnosis with ICD-10 code: E11.x for type 2 diabetes, I50.x for heart failure, or N18.x for chronic kidney disease.
2. Lab results: HbA1c within 90 days (for T2D), eGFR within 90 days, and BNP or NT-proBNP (for HF indication).
3. Prior therapy documentation: Most plans require proof that the patient tried metformin for at least 90 days (T2D) or is already on maximally tolerated ACE inhibitor or ARB therapy (CKD/HF).
4. Prescriber attestation: A statement confirming the patient meets the FDA-approved indication.
5. Supporting clinical notes: Recent office visit or telehealth visit notes showing the clinical rationale.

Denials happen. Missouri law gives patients the right to an expedited appeal, which insurers must resolve within 72 hours for urgent requests. The Missouri Department of Commerce and Insurance oversees the external review process if the internal appeal fails.

Pharmacy Access: Retail Chains, Mail-Order, and 503A Compounding

Missouri residents can fill a Farxiga prescription at any licensed retail pharmacy. CVS, Walgreens, and Walmart pharmacies stock the brand-name product across Missouri. Mail-order pharmacies like Express Scripts (headquartered in St. Louis) and CVS Caremark ship to Missouri addresses, often at lower 90-day supply copays.

503A compounding pharmacies in Missouri are licensed by the Missouri Board of Pharmacy and can compound dapagliflozin preparations under certain conditions. A 503A pharmacy compounds patient-specific prescriptions based on an individual prescription order. This route may be relevant if a patient needs a non-standard dose or cannot tolerate the commercial tablet formulation. Missouri 503A pharmacies can ship within the state. The FDA's compounding policy under section 503A of the FD&C Act applies.

A generic version of dapagliflozin is not yet available in the United States as of May 2026. AstraZeneca's composition-of-matter patent extends through 2025, but ongoing patent litigation and pediatric exclusivity extensions have kept generics off the market. When generics do launch, the price could drop 60-80% based on typical brand-to-generic price erosion patterns documented in FDA economic analyses.

Transferring a Farxiga Prescription to Missouri

If you move to Missouri or switch pharmacies, your existing Farxiga prescription can be transferred. Missouri allows prescription transfers between pharmacies for non-controlled substances with no restrictions on the number of remaining refills. The receiving pharmacy contacts the originating pharmacy, verifies the prescription, and processes the transfer electronically. This typically takes 1 to 3 business days.

One caveat: prior authorizations do not transfer between insurance plans. If you switch insurers after moving to Missouri, the new plan will require its own PA. Have your prescriber's office ready to submit a fresh authorization.

Timeline: From First Visit to First Dose

The realistic timeline for a Missouri patient starting from scratch:

• Day 1: Schedule telehealth or in-person visit. Provide existing labs or get an order for new labs.
• Days 2-5: Lab results return. Prescriber reviews results and writes prescription.
• Days 3-7: Prior authorization submitted. Commercial plans average 3-5 business days for standard requests.
• Days 5-10: PA approved (or denied, triggering appeal). Prescription sent to pharmacy.
• Days 7-14: Prescription filled and picked up, or shipped via mail-order (2-3 day shipping within Missouri).

Patients with recent labs and a cooperative insurer can have Farxiga in hand within a week. Complex PA cases or Medicaid exception requests may take 3 to 4 weeks.

Safety Monitoring After Starting Dapagliflozin

Prescribers in Missouri should follow the monitoring schedule recommended by the ADA Standards of Care and the ACC/AHA heart failure guideline (2022):

• Renal function (eGFR, creatinine): Recheck at 1 month, then every 3 to 6 months. An initial eGFR dip of 10-15% is expected and does not require stopping the drug. The DAPA-CKD data showed this early dip reversed by month 4, with long-term renal preservation outperforming placebo.
• Blood pressure: Dapagliflozin lowers systolic BP by an average of 3-5 mmHg. Patients on antihypertensives may need dose adjustments.
• Volume status: SGLT2 inhibitors cause mild osmotic diuresis. Patients taking loop diuretics may need diuretic dose reduction.
• Genital mycotic infections: The most common adverse event, affecting approximately 6-8% of women and 3-4% of men in clinical trials (FDA prescribing information). Standard antifungal treatment resolves most cases without stopping dapagliflozin.
• Ketone monitoring: Instruct patients to seek emergency care for nausea, vomiting, or abdominal pain, which may signal euglycemic DKA. This is rare (0.1-0.3%) but serious.

Cost-Reduction Strategies Specific to Missouri

Missouri patients have several options to lower out-of-pocket costs for Farxiga beyond standard insurance coverage:

• AstraZeneca Farxiga Savings Card: Eligible commercially insured patients may pay $0 per 30-day supply.
• Missouri Rx Plan (state discount program): Available to uninsured Missouri residents with income below 300% FPL. This program negotiates drug discounts through participating pharmacies.
• Patient Assistance Programs: AstraZeneca's AZ&Me program provides free Farxiga to patients without insurance who meet income criteria (generally below $50,000 for an individual).
• GoodRx / RxSaver coupons: Cash-pay prices for Farxiga in Missouri range from $480 to $580 for a 30-day supply at major chains. These discount tools can reduce that by 10-20%.
• 340B pharmacies: Federally qualified health centers in Missouri (there are over 30 FQHCs statewide) participate in the 340B Drug Pricing Program, which can significantly reduce the acquisition cost.